Readv this today
"Another company investigating COVID-ARDS is Mesoblast (MESO) which has a mesenchymal stem cell product, remestemcel-L, which is being trialed for end stage COVID-19, where the fatality rate is extremely high. Remestemcel-L is a very high cost live cell product which, even if it works, would have a limited market because of the very high cost"
from
https://seekingalpha.com/article/4352097-covidminus-19-gileads-remdesivir-might-be-good-gets?utm_medium=email&utm_source=seeking_alpha&mail_subject=must-read-boeing-stock-curb-your-enthusiasm&utm_campaign=nl-must-read&utm_content=link-3
banter and General Discussion, page-111
-
- There are more pages in this discussion • 10,371 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.063(5.84%) |
Mkt cap ! $1.147B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | $1.00 | $5.737M | 5.616M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 173663 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 107315 | 21 |
View Market Depth
| Last trade - 14.06pm 30/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |